A Phase 1 Study of Rucaparib Japanese Patients

Trial Profile

A Phase 1 Study of Rucaparib Japanese Patients

Recruiting
Phase of Trial: Phase I

Latest Information Update: 06 Mar 2018

At a glance

  • Drugs Rucaparib (Primary)
  • Indications Cancer; Solid tumours
  • Focus Adverse reactions
  • Acronyms RUCA-J
  • Sponsors Clovis Oncology
  • Most Recent Events

    • 06 Mar 2018 New trial record
    • 26 Feb 2018 According to a Clovis media release, this trial was initiated last week with the first patient dosed with rucaparib in Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top